Growth Metrics

Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2016 - 2025)

Idexx Laboratories has reported Non-Current Deferred Tax Liability over the past 17 years, most recently at $153.8 million for Q4 2025.

  • Quarterly results put Non-Current Deferred Tax Liability at $153.8 million for Q4 2025, up 1259.21% from a year ago — trailing twelve months through Dec 2025 was $153.8 million (up 1259.21% YoY), and the annual figure for FY2025 was $153.8 million, up 1259.21%.
  • Non-Current Deferred Tax Liability for Q4 2025 was $153.8 million at Idexx Laboratories, up from $3.7 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for IDXX hit a ceiling of $153.8 million in Q4 2025 and a floor of $2.1 million in Q2 2025.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $9.5 million (2021), compared with a mean of $21.1 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 92.57% in 2023 and later skyrocketed 1259.21% in 2025.
  • Idexx Laboratories' Non-Current Deferred Tax Liability stood at $8.9 million in 2021, then soared by 989.49% to $97.3 million in 2022, then crashed by 92.57% to $7.2 million in 2023, then soared by 56.35% to $11.3 million in 2024, then skyrocketed by 1259.21% to $153.8 million in 2025.
  • The last three reported values for Non-Current Deferred Tax Liability were $153.8 million (Q4 2025), $3.7 million (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.